Clinical Study
Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease
Table 1
Baseline characteristics of the patients before and after 12 months on PD treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant difference in the same group before (basal) and 12 months after PD treatment. **Significant difference between groups before the PD treatment. †Significant difference between groups 12 months after PD treatment. SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; Ca: calcium; P: phosphorous; PTH: parathyroid hormone; CRP: C reactive protein. |